Global Sodium Valproate Market Industry Analysis, Growth, Trends and Forecast - 2028

The global sodium valproate market is anticipated to grow at a CAGR of nearly 6.4% during the forecast period (2022-2028). Sodium valproate is an epilepsy drug prescribed for all seizure types including absence, myoclonus and tonic clonic seizures. The market growth is majorly attributable to the anticonvulsant properties of valproic acid and the development of valproic acid or valproate to market authorization for specific epilepsy types and syndromes, as well as their repurposing for other indications. Further, sodium valproate is also prescribed for patients who experience migraine headaches on a frequent basis. Thus, the growing prevalence of migraine, epilepsy, and convulsions coupled with the growing neurological disorders are anticipated to spur the growth of the global sodium valproate market.
As per the World Health Organization (WHO), an estimated 5 million people globally are diagnosed with epilepsy each year. In high-income countries, there are estimated to be 49 per 100,000 people diagnosed with epilepsy each year. In low- and middle-income countries, this figure can be as high as 139 per 100,000. New regulations introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) that states sodium valproate is prescribed to women and girls of childbearing age. Furthermore, as per the NCBI, considerable progress has been made for the treatment, understanding, and the prevention of hepatotoxicity caused on account of taking valproic acid/valproate. This is aimed to make its long-term administration safer. There are further ongoing attempts to reconsider valproate in combination with antipsychotic drugs so as to treat chronic diseases such as schizophrenia.

(Get 15% Discount on Buying this Report)

Get Sample Copy of Global Sodium Valproate Market at:
https://orionmarketreports.com/request-sample/?id=94305&submit=Request+Sample%0D%0A

Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

• Segment Covered-
o By Type
o By Application

• Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World

• Competitive Landscape: Sanofi S.A., AbbVie Inc., and Fresenius Kabi AG, among others.

Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

A full report of Global Sodium Valproate Market is available at:
https://orionmarketreports.com/global-sodium-valproate-market/94305/

Global Sodium Valproate Market Report by Segment

By Type
• Injection
• Tablet
• Others

By Application
• Epilepsy
• Migraine
• Others

Global Sodium Valproate Market Report by Region

North America
• US
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.